Strata Skin Sciences, Inc. SSKN
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 34.10% | -9.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 34.10% | -9.58% | |||
| Cost of Revenue | 33.99% | -18.23% | |||
| Gross Profit | 34.18% | -2.83% | |||
| SG&A Expenses | -6.12% | -8.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.34% | -11.14% | |||
| Operating Income | 101.99% | 16.50% | |||
| Income Before Tax | 104.32% | 34.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 103.58% | 34.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 103.58% | 34.83% | |||
| EBIT | 101.99% | 16.50% | |||
| EBITDA | 186.40% | 1.29% | |||
| EPS Basic | 102.76% | 39.35% | |||
| Normalized Basic EPS | 87.19% | 13.76% | |||
| EPS Diluted | 102.76% | 39.35% | |||
| Normalized Diluted EPS | 87.19% | 13.76% | |||
| Average Basic Shares Outstanding | 28.87% | 7.43% | |||
| Average Diluted Shares Outstanding | 28.87% | 7.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||